SEC Form 4 · accession 0001716950-18-000008
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Feinsod
Officer — Interim Chief Medical Officer
Period of report
Dec 11, 2017
Accepted (ET)
Apr 6, 2018 · 8:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 11, 2017 | F | 3,395 | $3.75 | D | 24,253 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares forfeited in connection with tax withholding as a result of vesting of restricted stock awarded on December 11, 2017.